Cargando…

Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development

Recently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Nghi M., Meyer, Daniel, Meyer, Luke, Chand, Subhash, Jagadesan, Sankarasubramanian, Miravite, Maireen, Guda, Chittibabu, Yelamanchili, Sowmya V., Pendyala, Gurudutt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047367/
https://www.ncbi.nlm.nih.gov/pubmed/36980307
http://dx.doi.org/10.3390/cells12060966
_version_ 1785013904306339840
author Nguyen, Nghi M.
Meyer, Daniel
Meyer, Luke
Chand, Subhash
Jagadesan, Sankarasubramanian
Miravite, Maireen
Guda, Chittibabu
Yelamanchili, Sowmya V.
Pendyala, Gurudutt
author_facet Nguyen, Nghi M.
Meyer, Daniel
Meyer, Luke
Chand, Subhash
Jagadesan, Sankarasubramanian
Miravite, Maireen
Guda, Chittibabu
Yelamanchili, Sowmya V.
Pendyala, Gurudutt
author_sort Nguyen, Nghi M.
collection PubMed
description Recently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment in children. However, molecular mechanisms contributing to such outcomes with long-term MDZ use during the early stages of life remain unclear. In this study, we for the first time elucidate the role of brain-derived extracellular vesicles (BDEVs), including mining the BDEV proteome post long-term MDZ exposure during early development. Employing our previously established rodent model system that mimics the exposure of MDZ in the NICU using an increasing dosage regimen, we isolated BDEVs from postnatal 21-days-old control and MDZ groups using a differential sucrose density gradient. BDEVs from the control and MDZ groups were then characterized using a ZetaView nanoparticle tracking analyzer and transmission electron microscopy analysis. Next, using RT-qPCR, we examined the expression of key ESCRT-related genes involved in EV biogenesis. Lastly, using quantitative mass spectrometry-based proteomics, we mined the BDEV protein cargo that revealed key differentially expressed proteins and associated molecular pathways to be altered post long-term MDZ exposure. Our study characterized the proteome in BDEV cargo from long-term MDZ exposure at early development. Importantly, we identified and validated the expression of YWHAH as a potential target for further characterization of its downstream mechanism and a potential biomarker for the early onset of neurodevelopment and neurodegenerative diseases. Overall, the present study demonstrated long-term exposure to MDZ at early development stages could influence BDEV protein cargo, which potentially impact neural functions and behavior at later stages of development.
format Online
Article
Text
id pubmed-10047367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100473672023-03-29 Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development Nguyen, Nghi M. Meyer, Daniel Meyer, Luke Chand, Subhash Jagadesan, Sankarasubramanian Miravite, Maireen Guda, Chittibabu Yelamanchili, Sowmya V. Pendyala, Gurudutt Cells Article Recently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment in children. However, molecular mechanisms contributing to such outcomes with long-term MDZ use during the early stages of life remain unclear. In this study, we for the first time elucidate the role of brain-derived extracellular vesicles (BDEVs), including mining the BDEV proteome post long-term MDZ exposure during early development. Employing our previously established rodent model system that mimics the exposure of MDZ in the NICU using an increasing dosage regimen, we isolated BDEVs from postnatal 21-days-old control and MDZ groups using a differential sucrose density gradient. BDEVs from the control and MDZ groups were then characterized using a ZetaView nanoparticle tracking analyzer and transmission electron microscopy analysis. Next, using RT-qPCR, we examined the expression of key ESCRT-related genes involved in EV biogenesis. Lastly, using quantitative mass spectrometry-based proteomics, we mined the BDEV protein cargo that revealed key differentially expressed proteins and associated molecular pathways to be altered post long-term MDZ exposure. Our study characterized the proteome in BDEV cargo from long-term MDZ exposure at early development. Importantly, we identified and validated the expression of YWHAH as a potential target for further characterization of its downstream mechanism and a potential biomarker for the early onset of neurodevelopment and neurodegenerative diseases. Overall, the present study demonstrated long-term exposure to MDZ at early development stages could influence BDEV protein cargo, which potentially impact neural functions and behavior at later stages of development. MDPI 2023-03-22 /pmc/articles/PMC10047367/ /pubmed/36980307 http://dx.doi.org/10.3390/cells12060966 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nguyen, Nghi M.
Meyer, Daniel
Meyer, Luke
Chand, Subhash
Jagadesan, Sankarasubramanian
Miravite, Maireen
Guda, Chittibabu
Yelamanchili, Sowmya V.
Pendyala, Gurudutt
Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_full Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_fullStr Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_full_unstemmed Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_short Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_sort identification of ywhah as a novel brain-derived extracellular vesicle marker post long-term midazolam exposure during early development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047367/
https://www.ncbi.nlm.nih.gov/pubmed/36980307
http://dx.doi.org/10.3390/cells12060966
work_keys_str_mv AT nguyennghim identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT meyerdaniel identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT meyerluke identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT chandsubhash identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT jagadesansankarasubramanian identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT miravitemaireen identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT gudachittibabu identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT yelamanchilisowmyav identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT pendyalagurudutt identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment